Leadership

Our team includes some of the world’s most respected oligonucleotide chemists, drug development experts and dedicated patient advocates.

Leadership Team

Paul Bolno, MD, MBA

President and Chief Executive Officer, Wave Life Sciences

Michael Panzara, MD, MPH

Chief Medical Officer, Head of Therapeutics Discovery and Development

Chandra Vargeese, PhD

Chief Technology Officer

Chris Francis, PhD

Senior Vice President, Corporate Development, Head of Emerging Areas

Kenneth Rhodes, PhD

Senior Vice President, Therapeutics Discovery

Kyle Moran

Senior Vice President, Finance and Operations

Linda Rockett, JD

General Counsel

José Juves

Senior Vice President, Corporate Affairs and Patient Advocacy

Board of Directors

Christian Henry, MBA

Chair, Wave Life Sciences
Formerly Executive Vice President and Chief Commercial Officer of Illumina, Inc.

Paul Bolno, MD, MBA

President and Chief Executive Officer, Wave Life Sciences

Mark H. N. Corrigan, MD

Chief Executive Officer, Correvio Pharma Corp.

Peter Kolchinsky, PhD

Managing General Partner, RA Capital Management

Aik Na Tan

Senior Vice-President (Administration), Nanyang Technological University, Singapore

Amy Pott

President, North America, SOBI

Adrian Rawcliffe

Chief Executive Officer, Adaptimmune Therapeutics plc

Ken Takanashi, MBA, CPA

Executive Vice President, Chief Operating Officer, Shin Nippon Biomedical Laboratories Ltd.

Gregory Verdine, PhD

President and CEO, FOG Pharmaceuticals

Heidi L. Wagner, JD

Senior Vice President, Government Affairs and Policy, Global Blood Therapeutics, Inc.